Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesSoluble Epoxide Hydrolase Gene Deletion Attenuates Renal Injury and Inflammation with DOCA-salt Hypertension
American Journal of Physiology: Renal Physiology, 06/25/09
Manhiani M et al. - The data demonstrate that Ephx2 gene deletion decreases blood pressure, attenuates renal inflammation, and ameliorates glomerular injury in DOCA-salt hypertension.
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cochrane Reviews, 10/23/09
The impact of stopping inhibitors of the renin–angiotensin system in patients with advanced chronic kidney disease
Nephrology Dialysis Transplantation, 10/13/09
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Arthritis Research & Therapy, 10/16/09
Today in Fluids and Electrolytes...keeping you current
Receive free subspecialty "5-minute updates" via email
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09
Does Diabetes Mellitus Predispose to Increased Fluid Overload in Peritoneal Dialysis Patients
Nephron: Clinical Practice, 10/12/09
Guided optimization of fluid status in haemodialysis patients
Nephrology Dialysis Transplantation, 10/02/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Article Search
Sponsor